HEALTHCARE TRIANGLE INC (HCTI)
US42227W2070 - Common Stock
Taking everything into account, HCTI scores 1 out of 10 in our fundamental rating. HCTI was compared to 37 industry peers in the Health Care Technology industry. Both the profitability and financial health of HCTI have multiple concerns. HCTI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
HCTI had negative earnings in the past year.
In the past year HCTI had a positive cash flow from operations.
In multiple years HCTI reported negative net income over the last 5 years.
In the past 5 years HCTI reported 4 times negative operating cash flow.
1.2 Ratios
HCTI has a worse Return On Assets (-176.78%) than 91.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -176.78% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-64.42%
ROA(5y)-31.58%
ROE(3y)-802.65%
ROE(5y)-458.86%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of HCTI (23.49%) is worse than 86.11% of its industry peers.
In the last couple of years the Gross Margin of HCTI has declined.
The Profit Margin and Operating Margin are not available for HCTI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 23.49% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5YN/A
2. Health
2.1 Basic Checks
HCTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HCTI has more shares outstanding
Compared to 1 year ago, HCTI has a worse debt to assets ratio.
2.2 Solvency
HCTI has an Altman-Z score of -8.43. This is a bad value and indicates that HCTI is not financially healthy and even has some risk of bankruptcy.
HCTI has a Altman-Z score of -8.43. This is amonst the worse of the industry: HCTI underperforms 86.11% of its industry peers.
HCTI has a debt to FCF ratio of 7.85. This is a slightly negative value and a sign of low solvency as HCTI would need 7.85 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.85, HCTI is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.85 | ||
| Altman-Z | -8.43 |
ROIC/WACCN/A
WACC15.06%
2.3 Liquidity
A Current Ratio of 0.38 indicates that HCTI may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.38, HCTI is doing worse than 88.89% of the companies in the same industry.
A Quick Ratio of 0.38 indicates that HCTI may have some problems paying its short term obligations.
HCTI has a Quick ratio of 0.38. This is amonst the worse of the industry: HCTI underperforms 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.38 | ||
| Quick Ratio | 0.38 |
3. Growth
3.1 Past
HCTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.85%, which is quite impressive.
The Revenue for HCTI has decreased by -47.29% in the past year. This is quite bad
The Revenue has been growing slightly by 1.94% on average over the past years.
EPS 1Y (TTM)21.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.37%
Revenue 1Y (TTM)-47.29%
Revenue growth 3Y1.94%
Revenue growth 5YN/A
Sales Q2Q%-65.02%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.66%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for HCTI. In the last year negative earnings were reported.
Also next year HCTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HCTI indicates a somewhat cheap valuation: HCTI is cheaper than 75.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.09 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
HCTI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HEALTHCARE TRIANGLE INC
NASDAQ:HCTI (11/22/2024, 6:37:09 PM)
1.09
+0.02 (+1.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.18M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -176.78% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 23.49% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.38 | ||
| Quick Ratio | 0.38 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)21.85%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-47.29%
Revenue growth 3Y1.94%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y